• Skip to main content

Plain Language Summaries

Standalone, citable summaries published in the Future Science Group journals written to be understood by a lay audience

  • How To Publish
  • How to Write Plain Language Summaries
  • Frequently Asked Questions
  • Publications
    • Animated Videos
    • Bladder, Kidney and Genitals
    • Brain and Nerves
    • Cancer
    • Diabetes and Metabolic Hormones
    • Eyes and Vision
    • Heart and Circulation
    • Infections
    • Inflammatory and Immune-related disorders
    • Mental Health
    • Muscle and Bone
    • Rare Diseases
    • Skin
    • Vaccines
  • Advisory Panel
  • Supporters
  • Blog
  • About Us
  • Contact Us

Mar 16 2022

How did transthyretin amyloid cardiomyopathy progress in patients who took placebo in the study ATTR-ACT? A plain language summary

A new plain language summary of publication published in Future Cardiology summarises some of the results of a study called ATTR-ACT. The article looked at the participants of the study who took placebo to learn how transthyretin amyloid cardiomyopathy progressed without treatment.

Read the article in full here.

Click here  to read the original article on which this summary is based.

  • Share on Twitter Share on Twitter
  • Share on Facebook Share on Facebook
  • Share on LinkedIn Share on LinkedIn

Written by Joanne Walker · Categorized: Heart and Circulation · Tagged: Amyloidosis, cardiomyopathy, heart failure, natural history, tafamidis, transthyretin amyloid cardiomyopathy

Copyright © 2023 · Plain Language Summaries · Terms and Conditions · Privacy Policy ·